Miles Wang's new AI-focused startup aims to accelerate drug discovery by repurposing existing drugs or failed candidates, leveraging prior safety data to potentially shorten development timelines. However, the significant time and cost of clinical trials remain a major hurdle that AI has not yet overcome. Separately, a new Illinois law mandates that AI developers earning over $500 million annually must report incidents within 72 hours, with a stricter 24-hour window for imminent death or injury, a measure supported by major AI labs. AI
IMPACT AI is being applied to accelerate drug discovery timelines, while new regulations are emerging to govern AI development and incident reporting.
RANK_REASON The cluster covers both a new AI startup focused on drug discovery and a significant state-level AI regulation.
Read on Mastodon — fosstodon.org →
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →
